Chris Gegenheimer is Chemonics’ director for monitoring, evaluation and learning rechnology and leads efforts in rolling out new data collection, management, analysis, and visualization technologies across home and project offices. Since joining Chemonics Mr. Gegenheimer has been in the MEL department supporting proposal and project teams in Latin America and the Caribbean, Asia, Africa, and the Middle East.

Chris Gray is head of environmental, social, and governance strategy and operations at Pfizer Inc. He is responsible for developing and implementing an enterprisewide approach to enhance ESG performance metrics and outcomes, co-chairs the Sustainability Steering Committee, and leads efforts to embed the ESG discipline into Pfizer business strategies. He also leads external ESG engagement and efforts to align Pfizer’s Purpose and ESG strategy with the Sustainable Development Goals and works closely with governments and civil society on strategic initiatives to improve global health and development.

Chris Humphrey is a senior research associate at the ODI global affairs think tank and senior scientist at ETH Zurich NADEL Center for Development and Cooperation.

Chris Jochnick is a global land rights expert and social entrepreneur with decades of experience in international development. Chris joined Landesa as CEO in August 2015 after leading Oxfam America’s work on business and development including shareholder engagement, value chain assessments, and collaborative advocacy initiatives, such as the “Behind the Brands” campaign. He is co-founder and former director of two pioneering nonprofit organizations: Center for Economic and Social Rights and the Ecuador-based Centros De Derechos Economicos y Sociales.

Chris Jurgens leads the global partnerships division in the Office of Innovation and Development Alliances at the U.S. Agency for International Development, which is responsible for providing overall leadership of the agency's public-private partnership efforts, many of which are established as Global Development Alliances.

Chris Karp is deputy director of global health discovery and translational sciences program at the Bill & Melinda Gates Foundation. He leads the vaccines and host-pathogen biology team that targets fundamental scientific and technological advances in global health that could lead to new ways to prevent and treat disease. Prior to joining the foundation in 2012, he was on the faculty of the departments of medicine and molecular microbiology and immunology at Johns Hopkins University School of Medicine, and founded the division of molecular immunology at Cincinnati Children's Hospital Research Foundation, where he was Esiason/Bell Professor of Pediatrics.

Chris LeGrand, president of DAI Global Health, has 30 years of experience creating health solutions for both the public and private sector. He is passionate about the possibility of putting health technology and knowledge in the hands of citizens, empowering them to take charge of their own health and well-being. Chris recently published a book, "The Complete Business Leader: A Framework for Impact in Work and Life."

Chris Macek is CEO of SystemOne, a global leader in moving infectious disease diagnostic data and turning it into actionable intelligence for patients, ministries of health, global funders, and other health systems participants. Chris was previously founder and CEO of Relyon Media, which developed large-scale software applications for U.S.-based government projects, universities, and the World Bank.

Chris McKeon is a writer and production assistant at Arete Stories, a leading provider of multimedia communications support and training throughout East Africa, including Somalia. He has an MPhil in African Studies from the University of Cambridge, where he wrote his thesis on land tenure reform in Kenya.

Christopher Mellon is a policy analyst for New America’s Future of Property Rights program.